Sphingolipids in cancer

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 567-576

  Furuya, Hideki ^a   Shimizu, Yoshiko ^a   Kawamori, Toshihiko ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Breast cancer; Cancer development and therapy; Colon cancer; Head and neck cancer; Prostate cancer; Sphingolipids

Indexed keywords

BETA CATENIN; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; CONNEXIN 43; CYCLOOXYGENASE 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN BCL 2; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; COLON CANCER; HEAD AND NECK CANCER; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFLAMMATION; MALE; PROSTATIC NEOPLASMS; SPHINGOLIPIDS;

EID: 83855164064     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9304-1     Document Type: Review

References (117)

1. S Spiegel S Milstien 2003 Sphingosine-1-phosphate: an enigmatic signalling lipid Nature Reviews Molecular Cell Biology 4 397 407 12728273 1:CAS:528:DC%2BD3sXjtlalt7o%3D 10.1038/nrm1103
2. B Ogretmen YA Hannun 2004 Biologically active sphingolipids in cancer pathogenesis and treatment Nature Reviews. Cancer 4 604 616 15286740 1:CAS:528:DC%2BD2cXmtVOhsb4%3D 10.1038/nrc1411
3. YA Hannun LM Obeid 2008 Principles of bioactive lipid signalling: lessons from sphingolipids Nature Reviews Molecular Cell Biology 9 139 150 18216770 1:CAS:528:DC%2BD1cXovFOntg%3D%3D 10.1038/nrm2329
4. YA Hannun LM Obeid 2002 The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind Journal of Biological Chemistry 277 25847 25850 12011103 1:CAS:528:DC%2BD38XlsFKrs74%3D 10.1074/jbc.R200008200
5. SC Linn HS Kim EM Keane LM Andras E Wang AH Merrill Jr 2001 Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption Biochemical Society Transactions 29 831 835 11709083 1:CAS:528: DC%2BD3MXpt1Crtr8%3D 10.1042/BST0290831
6. Y Pewzner-Jung S Ben-Dor AH Futerman 2006 When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: insights into the regulation of ceramide synthesis Journal of Biological Chemistry 281 25001 25005 16793762 1:CAS:528:DC%2BD28XoslKmurg%3D 10.1074/jbc.R600010200
7. FG Tafesse P Ternes JC Holthuis 2006 The multigenic sphingomyelin synthase family Journal of Biological Chemistry 281 29421 29425 16905542 1:CAS:528:DC%2BD28XhtVahsLnF 10.1074/jbc.R600021200
8. A Raas-Rothschild I Pankova-Kholmyansky Y Kacher AH Futerman 2004 Glycosphingolipidoses: beyond the enzymatic defect Glycoconjugate Journal 21 295 304 15514478 1:CAS:528:DC%2BD2cXptVOhu7o%3D 10.1023/B:GLYC.0000046272.38480.ef
9. N Marchesini YA Hannun 2004 Acid and neutral sphingomyelinases: roles and mechanisms of regulation Biochemistry and Cell Biology 82 27 44 15052326 1:CAS:528:DC%2BD2cXjtVeiu7k%3D 10.1139/o03-091
10. S Hakomori 2000 Traveling for the glycosphingolipid path Glycoconjugate Journal 17 627 647 11421354 1:CAS:528:DC%2BD3MXksVOgtb8%3D 10.1023/A: 1011086929064
11. S Ichikawa Y Hirabayashi 1998 Glucosylceramide synthase and glycosphingolipid synthesis Trends in Cell Biology 8 198 202 9695839 1:CAS:528:DyaK1cXjtFyjsrs%3D 10.1016/S0962-8924(98)01249-5
12. R Xu J Jin W Hu W Sun J Bielawski Z Szulc, et al. 2006 Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P The FASEB Journal 20 1813 1825 16940153 1:CAS:528: DC%2BD28XptlKjsb8%3D 10.1096/fj.05-5689com
13. S Galadari BX Wu C Mao P Roddy S El Bawab YA Hannun 2006 Identification of a novel amidase motif in neutral ceramidase Biochemical Journal 393 687 695 16229686 1:CAS:528:DC%2BD28XmtlOlsQ%3D%3D 10.1042/BJ20050682
14. NC Hait CA Oskeritzian SW Paugh S Milstien S Spiegel 2006 Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases Biochimica et Biophysica Acta 1758 2016 2026 16996023 1:CAS:528:DC%2BD28Xht12kt7zJ 10.1016/j.bbamem.2006.08.007
15. KR Johnson KY Johnson KP Becker J Bielawski C Mao LM Obeid 2003 Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability Journal of Biological Chemistry 278 34541 34547 12815058 1:CAS:528:DC%2BD3sXmvVCqt7s%3D 10.1074/jbc.M301741200
16. DN Brindley 2004 Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer Journal of Cellular Biochemistry 92 900 912 15258914 1:CAS:528:DC%2BD2cXmtlClsb8%3D 10.1002/jcb.20126
17. YJ Sigal MI McDermott AJ Morris 2005 Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions Biochemical Journal 387 281 293 15801912 1:CAS:528:DC%2BD2MXivFWls74%3D 10.1042/BJ20041771
18. P Bandhuvula JD Saba 2007 Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren Trends in Molecular Medicine 13 210 217 17416206 1:CAS:528:DC%2BD2sXlt1aks7g%3D 10.1016/j.molmed.2007.03.005
19. LM Obeid CM Linardic LA Karolak YA Hannun 1993 Programmed cell death induced by ceramide Science 259 1769 1771 8456305 1:CAS:528:DyaK3sXisFagtbg%3D 10.1126/science.8456305
20. ME Venable JY Lee MJ Smyth A Bielawska LM Obeid 1995 Role of ceramide in cellular senescence Journal of Biological Chemistry 270 30701 30708 8530509 1:CAS:528:DyaK28XhtFKksw%3D%3D 10.1074/jbc.270.51.30701
21. T Hla 2004 Physiological and pathological actions of sphingosine 1-phosphate Seminars in Cell & Developmental Biology 15 513 520 1:CAS:528:DC%2BD2cXmtVaitb4%3D 10.1016/j.semcdb.2004.05.002
22. X Liu JC Cheng LS Turner S Elojeimy TH Beckham A Bielawska, et al. 2009 Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy Expert Opinion on Therapeutic Targets 13 1449 1458 19874262 1:CAS:528:DC%2BD1MXhsVCku77L 10.1517/14728220903357512
23. PK Dudeja R Dahiya TA Brasitus 1986 The role of sphingomyelin synthetase and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations of rat colonic plasma membranes Biochimica et Biophysica Acta 863 309 312 3024722 1:CAS:528:DyaL2sXpslOktA%3D%3D 10.1016/0005-2736(86)90272-5
24. DL Dillehay SK Webb EM Schmelz AH Merrill Jr 1994 Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice Journal of Nutrition 124 615 620 8169652 1:CAS:528:DyaK2cXivFOgurY%3D
25. EM Schmelz DL Dillehay SK Webb A Reiter J Adams AH Merrill Jr 1996 Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis Cancer Research 56 4936 4941 8895747 1:CAS:528:DyaK28XmsFygtrs%3D
26. EM Schmelz AS Bushnev DL Dillehay MC Sullards DC Liotta AH Merrill Jr 1999 Ceramide-beta-d-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis Cancer Research 59 5768 5772 10582697 1:CAS:528:DyaK1MXnslyhurg%3D
27. EM Schmelz AS Bushnev DL Dillehay DC Liotta AH Merrill Jr 1997 Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones Nutrition and Cancer 28 81 85 9200154 1:CAS:528:DyaK2sXktlSktbo%3D 10.1080/01635589709514556
28. H Symolon EM Schmelz DL Dillehay AH Merrill Jr 2004 Dietary soy sphingolipids suppress tumorigenesis and gene expression in 1,2- dimethylhydrazine-treated CF1 mice and ApcMin/+ mice Journal of Nutrition 134 1157 1161 15113963 1:CAS:528:DC%2BD2cXjvFGqu74%3D
29. EM Schmelz MC Sullards DL Dillehay AH Merrill Jr 2000 Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice Journal of Nutrition 130 522 527 10702579 1:CAS:528:DC%2BD3cXhsFChu7Y%3D
30. EM Schmelz PC Roberts EM Kustin LA Lemonnier MC Sullards DL Dillehay, et al. 2001 Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids Cancer Research 61 6723 6729 11559543 1:CAS:528:DC%2BD3MXntFaisL4%3D
31. LA Lemonnier DL Dillehay MJ Vespremi J Abrams E Brody EM Schmelz 2003 Sphingomyelin in the suppression of colon tumors: prevention versus intervention Archives of Biochemistry and Biophysics 419 129 138 14592456 1:CAS:528:DC%2BD3sXosVyhu7w%3D 10.1016/j.abb.2003.08.023
32. Mazzei, J. C., Zhou, H., Brayfield, B. P., Hontecillas, R., Bassaganya-Riera, J., & Schmelz, E. M. (2011). Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor gamma expression. Journal of Nutritional Biochemistry (in press).
33. T Hla 2003 Signaling and biological actions of sphingosine 1-phosphate Pharmacological Research 47 401 407 12676514 1:CAS:528:DC%2BD3sXisFWlsb8%3D 10.1016/S1043-6618(03)00046-X
34. ML Allende RL Proia 2002 Sphingosine-1-phosphate receptors and the development of the vascular system Biochimica et Biophysica Acta 1582 222 227 12069832 1:CAS:528:DC%2BD38XksF2htLg%3D
35. MJ Lee S Thangada KP Claffey N Ancellin CH Liu M Kluk, et al. 1999 Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate Cell 99 301 312 10555146 1:CAS:528:DyaK1MXnt1Gqs7o%3D 10.1016/S0092-8674(00)81661-X
36. B Visentin JA Vekich BJ Sibbald AL Cavalli KM Moreno RG Matteo, et al. 2006 Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages Cancer Cell 9 225 238 16530706 1:CAS:528:DC%2BD28XivFWjtLs%3D 10.1016/j.ccr.2006.02.023
37. T Kawamori W Osta KR Johnson BJ Pettus J Bielawski T Tanaka, et al. 2006 Sphingosine kinase 1 is up-regulated in colon carcinogenesis The FASEB Journal 20 386 388 16319132 1:CAS:528:DC%2BD28XhsFOksb8%3D
38. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 7926468 1:STN:280: DyaK2M%2FhtFamsA%3D%3D
39. M Oshima JE Dinchuk SL Kargman H Oshima B Hancock E Kwong, et al. 1996 Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 803 809 8945508 1:CAS:528:DyaK28XntlymsLc%3D 10.1016/S0092-8674(00)81988-1
40. K Watanabe T Kawamori S Nakatsugi T Ohta S Ohuchida H Yamamoto, et al. 1999 Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Research 59 5093 5096 10537280 1:CAS:528:DyaK1MXmvFelsrs%3D
41. M Sonoshita K Takaku N Sasaki Y Sugimoto F Ushikubi S Narumiya, et al. 2001 Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice Nature Medicine 7 1048 1051 11533709 1:CAS:528:DC%2BD3MXmvFOls7Y%3D 10.1038/nm0901-1048
42. T Kawamori CV Rao K Seibert BS Reddy 1998 Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis Cancer Research 58 409 412 9458081 1:CAS:528:DyaK1cXnsFejtw%3D%3D
43. AJ Snider T Kawamori SG Bradshaw KA Orr GS Gilkeson YA Hannun, et al. 2009 A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis The FASEB Journal 23 143 152 18815359 1:CAS:528:DC%2BD1MXlsVOlsQ%3D%3D 10.1096/fj.08-118109
44. T Kawamori T Kaneshiro M Okumura S Maalouf A Uflacker J Bielawski, et al. 2009 Role for sphingosine kinase 1 in colon carcinogenesis The FASEB Journal 23 405 414 18824518 1:CAS:528:DC%2BD1MXhs1Kmurw%3D 10.1096/fj.08-117572
45. M Kohno M Momoi ML Oo JH Paik YM Lee K Venkataraman, et al. 2006 Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation Molecular and Cellular Biology 26 7211 7223 16980623 1:CAS:528:DC%2BD28XhtVCltbfM 10.1128/MCB.02341-05
46. LW Maines LR Fitzpatrick KJ French Y Zhuang Z Xia SN Keller, et al. 2008 Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase Digestive Diseases and Sciences 53 997 1012 18058233 1:CAS:528:DC%2BD1cXjt1Wiurw%3D 10.1007/s10620-007-0133-6
47. AA Chumanevich D Poudyal X Cui T Davis PA Wood CD Smith, et al. 2010 Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase Carcinogenesis 31 1787 1793 20688834 1:CAS:528:DC%2BC3cXht1Ogtb7J 10.1093/carcin/bgq158
48. B Oskouian P Sooriyakumaran AD Borowsky A Crans L Dillard-Telm YY Tam, et al. 2006 Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer Proceedings of the National Academy of Sciences of the United States of America 103 17384 17389 17090686 1:CAS:528:DC%2BD28Xht1KqsbfF 10.1073/pnas.0600050103
49. K Kimura C Bowen S Spiegel EP Gelmann 1999 Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis Cancer Research 59 1606 1614 10197636 1:CAS:528:DyaK1MXisVWku7w%3D
50. A Haimovitz-Friedman CC Kan D Ehleiter RS Persaud M McLoughlin Z Fuks, et al. 1994 Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis The Journal of Experimental Medicine 180 525 535 8046331 1:CAS:528:DyaK2cXltVeit70%3D 10.1084/jem.180.2.525
51. SJ Chmura E Nodzenski MA Beckett DW Kufe J Quintans RR Weichselbaum 1997 Loss of ceramide production confers resistance to radiation-induced apoptosis Cancer Research 57 1270 1275 9102212 1:CAS:528:DyaK2sXit1Oju78%3D
52. VE Nava O Cuvillier LC Edsall K Kimura S Milstien EP Gelmann, et al. 2000 Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells Cancer Research 60 4468 4474 10969794 1:CAS:528:DC%2BD3cXmsVahsrw%3D
53. JS Norris A Bielawska T Day A El-Zawahri S ElOjeimy Y Hannun, et al. 2006 Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report Cancer Gene Therapy 13 1045 1051 16763610 1:CAS:528:DC%2BD28Xht1SgtrfM 10.1038/sj.cgt. 7700965
54. RS Seelan C Qian A Yokomizo DG Bostwick DI Smith W Liu 2000 Human acid ceramidase is overexpressed but not mutated in prostate cancer Genes, Chromosomes & Cancer 29 137 146 1:CAS:528:DC%2BD3cXntVWiurg%3D 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E
55. AF Saad WD Meacham A Bai V Anelli S Elojeimy AE Mahdy, et al. 2007 The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy Cancer Biology & Therapy 6 1455 1460 1:CAS:528:DC%2BD1cXhtlCitb8%3D 10.4161/cbt.6.9.4623
56. AE Mahdy JC Cheng J Li S Elojeimy WD Meacham LS Turner, et al. 2009 Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer Molecular Therapy 17 430 438 19107118 1:CAS:528:DC%2BD1cXhsFart7fF 10.1038/mt.2008.281
57. S Spiegel O Cuvillier LC Edsall T Kohama R Menzeleev Z Olah, et al. 1998 Sphingosine-1-phosphate in cell growth and cell death Annals of the New York Academy of Sciences 845 11 18 9668339 1:CAS:528:DyaK1cXks12htb0%3D 10.1111/j.1749-6632.1998.tb09658.x
58. O Cuvillier G Pirianov B Kleuser PG Vanek OA Coso S Gutkind, et al. 1996 Suppression of ceramide-mediated programmed cell death by sphingosine-1- phosphate Nature 381 800 803 8657285 1:CAS:528:DyaK28XjvVKnsro%3D 10.1038/381800a0
59. M Sauane ZZ Su R Dash X Liu JS Norris D Sarkar, et al. 2010 Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis Journal of Cellular Physiology 222 546 555 19937735 1:CAS:528:DC%2BC3cXjt1Sn
60. JD Wang S Takahara N Nonomura N Ichimaru K Toki H Azuma, et al. 1999 Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation Prostate 40 50 55 10344723 1:CAS:528:DyaK1MXjslOlsLg%3D 10.1002/(SICI)1097-0045(19990615)40:1<50::AID- PROS6>3.0.CO;2-N
61. S Permpongkosol JD Wang S Takahara K Matsumiya N Nonomura K Nishimura, et al. 2002 Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis International Journal of Cancer 98 167 172 1:CAS:528:DC%2BD38XhsVSktb8%3D 10.1002/ijc.10178
62. CW Chua DT Lee MT Ling C Zhou K Man J Ho, et al. 2005 FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer International Journal of Cancer 117 1039 1048 1:CAS:528:DC%2BD2MXht1Cntb7P 10.1002/ijc.21243
63. Y Akao Y Banno Y Nakagawa N Hasegawa TJ Kim T Murate, et al. 2006 High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation Biochemical and Biophysical Research Communications 342 1284 1290 16516161 1:CAS:528:DC%2BD28Xit1yntLo%3D 10.1016/j.bbrc.2006.02.070
64. D Pchejetski N Doumerc M Golzio M Naymark J Teissie T Kohama, et al. 2008 Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models Molecular Cancer Therapeutics 7 1836 1845 18644996 1:CAS:528:DC%2BD1cXoslCgtLY%3D 10.1158/1535-7163.MCT-07-2322
65. AC Mulders S Nau Y Li MC Michel 2007 Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines Autonomic & Autacoid Pharmacology 27 173 179 1:CAS:528:DC%2BD1cXjtFWgug%3D%3D 10.1111/j.1474-8673.2007.00410.x
66. A Lucci WI Cho TY Han AE Giuliano DL Morton MC Cabot 1998 Glucosylceramide: a marker for multiple-drug resistant cancers Anticancer Research 18 475 480 9568165 1:STN:280:DyaK1c3ivFGrtw%3D%3D
67. Y Lavie H Cao SL Bursten AE Giuliano MC Cabot 1996 Accumulation of glucosylceramides in multidrug-resistant cancer cells Journal of Biological Chemistry 271 19530 19536 8702646 1:CAS:528:DyaK28XkvFymtL0%3D 10.1074/jbc.271.32.19530
68. YY Liu TY Han AE Giuliano MC Cabot 2001 Ceramide glycosylation potentiates cellular multidrug resistance The FASEB Journal 15 719 730 11259390 1:CAS:528:DC%2BD3MXitFWmsLk%3D 10.1096/fj.00-0223com
69. YY Liu TY Han JY Yu A Bitterman A Le AE Giuliano, et al. 2004 Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells Journal of Lipid Research 45 933 940 14967819 1:CAS:528:DC%2BD2cXjsFKis7k%3D 10.1194/jlr.M300486-JLR200
70. V Gouaze JY Yu RJ Bleicher TY Han YY Liu H Wang, et al. 2004 Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy Molecular Cancer Therapeutics 3 633 639 15141021 1:CAS:528:DC%2BD2cXjvVKntbc%3D
71. YY Liu V Gupta GA Patwardhan K Bhinge Y Zhao J Bao, et al. 2010 Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling Molecular Cancer 9 145 20540746 10.1186/1476-4598-9-145 1:CAS:528:DC%2BC3cXnvFSlt7w%3D
72. E Ruckhaberle T Karn L Hanker R Gatje D Metzler U Holtrich, et al. 2009 Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer Journal of Cancer Research and Clinical Oncology 135 81 90 18560890 10.1007/s00432-008-0436-9 1:CAS:528:DC%2BD1cXhsVWhtLrI
73. V Gouaze YY Liu CS Prickett JY Yu AE Giuliano MC Cabot 2005 Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs Cancer Research 65 3861 3867 15867385 1:CAS:528:DC%2BD2MXjslGks7k%3D 10.1158/0008-5472.CAN-04-2329
74. B Ogretmen 2006 Sphingolipids in cancer: regulation of pathogenesis and therapy FEBS Letters 580 5467 5476 16970943 1:CAS:528:DC%2BD28XhtVajsr7K 10.1016/j.febslet.2006.08.052
75. S Schiffmann J Sandner K Birod I Wobst C Angioni E Ruckhaberle, et al. 2009 Ceramide synthases and ceramide levels are increased in breast cancer tissue Carcinogenesis 30 745 752 19279183 1:CAS:528:DC%2BD1MXlsVChtLk%3D 10.1093/carcin/bgp061
76. AP Struckhoff R Bittman ME Burow S Clejan S Elliott T Hammond, et al. 2004 Novel ceramide analogs as potential chemotherapeutic agents in breast cancer Journal of Pharmacology and Experimental Therapeutics 309 523 532 14742741 1:CAS:528:DC%2BD2cXjs1yhtbk%3D 10.1124/jpet.103.062760
77. JW Antoon J Liu MM Gestaut ME Burow BS Beckman M Foroozesh 2009 Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells Journal of Medicinal Chemistry 52 5748 5752 19694470 1:CAS:528:DC%2BD1MXhtVWkurfL 10.1021/jm9009668
78. JW Antoon J Liu AP Ponnapakkam MM Gestaut M Foroozesh BS Beckman 2010 Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics Cancer Chemotherapy and Pharmacology 65 1191 1195 20155475 1:CAS:528:DC%2BC3cXjtlalsb4%3D 10.1007/s00280-009-1233-0
79. EJ Goetzl H Dolezalova Y Kong L Zeng 1999 Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells Cancer Research 59 4732 4737 10493533 1:CAS:528:DyaK1MXmtVKktL4%3D
80. F Wang K Nohara A Olivera EW Thompson S Spiegel 1999 Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate Experimental Cell Research 247 17 28 10047444 1:CAS:528:DyaK1MXht12ku7s%3D 10.1006/excr.1998.4327
81. VE Nava JP Hobson S Murthy S Milstien S Spiegel 2002 Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells Experimental Cell Research 281 115 127 12441135 1:CAS:528:DC%2BD38XosFOgurs%3D 10.1006/excr.2002.5658
82. S Spiegel A Olivera H Zhang EW Thompson Y Su A Berger 1994 Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells Breast Cancer Research and Treatment 31 337 348 7881110 1:CAS:528:DyaK2MXit1alurk%3D 10.1007/BF00666166
83. KJ French RS Schrecengost BD Lee Y Zhuang SN Smith JL Eberly, et al. 2003 Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Research 63 5962 5969 14522923 1:CAS:528:DC%2BD3sXnvVSisLk%3D
84. O Sukocheva C Wadham P Xia 2009 Role of sphingolipids in the cytoplasmic signaling of estrogens Steroids 74 562 567 19167412 1:CAS:528: DC%2BD1MXksVCksbs%3D 10.1016/j.steroids.2008.12.014
85. OA Sukocheva L Wang N Albanese SM Pitson MA Vadas P Xia 2003 Sphingosine kinase transmits estrogen signaling in human breast cancer cells Molecular Endocrinology 17 2002 2012 12881510 1:CAS:528:DC%2BD3sXotFSrsLY%3D 10.1210/me.2003-0119
86. O Sukocheva C Wadham A Holmes N Albanese E Verrier F Feng, et al. 2006 Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 The Journal of Cell Biology 173 301 310 16636149 1:CAS:528:DC%2BD28XktVCnsrw%3D 10.1083/jcb.200506033
87. K Takabe RH Kim JC Allegood P Mitra S Ramachandran M Nagahashi, et al. 2010 Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2 Journal of Biological Chemistry 285 10477 10486 20110355 1:CAS:528:DC%2BC3cXjvFajtbk%3D 10.1074/jbc.M109.064162
88. H Wakita Y Tokura H Yagi K Nishimura F Furukawa M Takigawa 1994 Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine Archives for Dermatological Research 286 350 354 1:CAS:528:DyaK2MXhtVKltrc%3D 10.1007/BF00402228
89. C Rodriguez-Lafrasse G Alphonse P Broquet MT Aloy P Louisot R Rousson 2001 Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosis Biochemical Journal 357 407 416 11439090 1:CAS:528:DC%2BD3MXls1Shu78%3D 10.1042/0264-6021:3570407
90. SJ Chmura HJ Mauceri S Advani R Heimann MA Beckett E Nodzenski, et al. 1997 Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation Cancer Research 57 4340 4347 9331096 1:CAS:528:DyaK2sXmsFCgsrw%3D
91. G Alphonse C Bionda MT Aloy D Ardail R Rousson C Rodriguez-Lafrasse 2004 Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels Oncogene 23 2703 2715 15048093 1:CAS:528: DC%2BD2cXivV2ju78%3D 10.1038/sj.onc.1207357
92. D Separovic J Bielawski JS Pierce S Merchant AL Tarca B Ogretmen, et al. 2009 Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas British Journal of Cancer 100 626 632 19223911 1:CAS:528:DC%2BD1MXit1Oktbs%3D 10.1038/sj.bjc.6604896
93. S Mehta D Blackinton I Omar N Kouttab D Myrick J Klostergaard, et al. 2000 Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line Cancer Chemotherapy and Pharmacology 46 85 92 10972477 1:CAS:528:DC%2BD3cXltFKhs78%3D 10.1007/s002800000140
94. CE Senkal S Ponnusamy MJ Rossi K Sundararaj Z Szulc J Bielawski, et al. 2006 Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 317 1188 1199 16510697 1:CAS:528:DC%2BD28Xlt1eqtb8%3D 10.1124/jpet.106.101949
95. MJ Rossi K Sundararaj S Koybasi MS Phillips ZM Szulc A Bielawska, et al. 2005 Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells Otolaryngology - Head and Neck Surgery 132 55 62 15632910 10.1016/j.otohns.2004.08.015
96. K Fujiwara K Kitatani K Fukushima H Yazama H Umehara M Kikuchi, et al. 2011 Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice International Journal of Clinical Oncology 16 133 140 21057846 1:CAS:528:DC%2BC3MXktlyqurw%3D 10.1007/s10147-010-0141-y
97. 18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas Journal of Biological Chemistry 279 44311 44319 15317812 1:CAS:528: DC%2BD2cXosFyms7k%3D 10.1074/jbc.M406920200
98. S Karahatay K Thomas S Koybasi CE Senkal S Elojeimy X Liu, et al. 2007 Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis Cancer Letters 256 101 111 17619081 1:CAS:528:DC%2BD2sXpvFGrtLs%3D 10.1016/j.canlet. 2007.06.003
99. CE Senkal S Ponnusamy MJ Rossi J Bialewski D Sinha JC Jiang, et al. 2007 Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas Molecular Cancer Therapeutics 6 712 722 17308067 1:CAS:528:DC%2BD2sXhvVWrt70%3D 10.1158/1535-7163.MCT-06-0558
100. CE Senkal S Ponnusamy J Bielawski YA Hannun B Ogretmen 2010 Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways The FASEB Journal 24 296 308 19723703 10.1096/fj.09-135087 1:CAS:528:DC%2BC3cXmtVGquw%3D%3D
101. K Shirai T Kaneshiro M Wada H Furuya J Bielawski YA Hannun, et al. 2011 A role of sphingosine kinase 1 in head and neck carcinogenesis Cancer Prevention Research (Philadelphia, Pa.) 4 454 462 1:CAS:528:DC%2BC3MXktl2lurw%3D 10.1158/1940-6207.CAPR-10-0299
102. MY Kim C Linardic L Obeid Y Hannun 1991 Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation Journal of Biological Chemistry 266 484 489 1845977 1:CAS:528:DyaK3MXpvFOitQ%3D%3D
103. Y Baran A Salas CE Senkal U Gunduz J Bielawski LM Obeid, et al. 2007 Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells Journal of Biological Chemistry 282 10922 10934 17303574 1:CAS:528:DC%2BD2sXjvFags78%3D 10.1074/jbc.M610157200
104. QF Li CT Wu Q Guo H Wang LS Wang 2008 Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis Biochemical and Biophysical Research Communications 371 159 162 18423379 1:CAS:528:DC%2BD1cXlvVWgtr4%3D 10.1016/j.bbrc.2008.04.037
105. SW Paugh BS Paugh M Rahmani D Kapitonov JA Almenara T Kordula, et al. 2008 A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Blood 112 1382 1391 18511810 1:CAS:528:DC%2BD1cXpvVOktLc%3D 10.1182/blood-2008-02-138958
106. A Prinetti L Basso V Appierto MG Villani M Valsecchi N Loberto, et al. 2003 Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells Journal of Biological Chemistry 278 5574 5583 12486134 1:CAS:528:DC%2BD3sXht1aqs70%3D 10.1074/jbc.M207269200
107. A Prinetti D Millimaggi S D'Ascenzo M Clarkson A Bettiga V Chigorno, et al. 2006 Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells Biochemical Journal 395 311 318 16356169 1:CAS:528:DC%2BD28XjtVWjsro%3D 10.1042/BJ20051184
108. KM Devine Y Smicun JM Hope DA Fishman 2008 S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac Gynecologic Oncology 110 237 245 18513786 1:CAS:528: DC%2BD1cXoslWmtro%3D 10.1016/j.ygyno.2008.04.013
109. Y Smicun S Reierstad FQ Wang C Lee DA Fishman 2006 S1P regulation of ovarian carcinoma invasiveness Gynecologic Oncology 103 952 959 16956652 1:CAS:528:DC%2BD28Xht1KgtLfF 10.1016/j.ygyno.2006.06.036
110. Z Cakir G Saydam F Sahin Y Baran 2011 The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells Journal of Cancer Research and Clinical Oncology 137 279 286 20401667 1:CAS:528:DC%2BC3MXkt1SnsQ%3D%3D 10.1007/s00432-010-0884-x
111. SM Kurinna CC Tsao AF Nica T Jiffar PP Ruvolo 2004 Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase Cancer Research 64 7852 7856 15520191 1:CAS:528: DC%2BD2cXptFelsr4%3D 10.1158/0008-5472.CAN-04-1552
112. KR Johnson KY Johnson HG Crellin B Ogretmen AM Boylan RA Harley, et al. 2005 Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue Journal of Histochemistry and Cytochemistry 53 1159 1166 15923363 1:CAS:528:DC%2BD2MXhtVersbrP 10.1369/jhc.4A6606.2005
113. D Shida J Kitayama H Yamaguchi H Yamashita K Mori T Watanabe, et al. 2004 Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells FEBS Letters 577 333 338 15556605 1:CAS:528:DC%2BD2cXhtVSrtLjM 10.1016/j.febslet.2004.10.024
114. JR Van Brocklyn CA Jackson DK Pearl MS Kotur PJ Snyder TW Prior 2005 Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines Journal of Neuropathology and Experimental Neurology 64 695 705 16106218 10.1097/01.jnen.0000175329.59092.2c
115. W Wu X Shu H Hovsepyan RD Mosteller D Broek 2003 VEGF receptor expression and signaling in human bladder tumors Oncogene 22 3361 3370 12776187 1:CAS:528:DC%2BD3sXktVyksrk%3D 10.1038/sj.onc.1206285
116. L Qiu C Zhou Y Sun W Di E Scheffler S Healey, et al. 2006 Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells Oncology Reports 16 907 913 16969513 1:CAS:528:DC%2BD28XhtFSisrrE
117. J Guillermet-Guibert L Davenne D Pchejetski N Saint-Laurent L Brizuela C Guilbeau-Frugier, et al. 2009 Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug Molecular Cancer Therapeutics 8 809 820 19372554 1:CAS:528:DC%2BD1MXks1amsbc%3D 10.1158/1535-7163.MCT-08-1096